Cynthia Fisher

ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA.

Viacord, Inc. provides umbilical cord blood stem cell preservation services. The company stores blood from a newborns umbilical cord for future use. It develops cell product candidates for cancer, cardiac disease, and diabetes. Viacord was founded in January, 1993 and is headquartered in Cambridge, MA

The National Park Foundation is a non-profit organization that partners with the National Park Service to raise private funds for the conservation and preservation of over 84 million acres of national parks in the United States. The National Park Foundation is based in Washington, and the CEO of the non-profit company is Will Shafroth. The company aims to connect Americans with the natural landscapes, culture, and history of these parks, and engage the next generation of park stewards. The organization collaborates with the National Park Service and the park partner community, and relies on the generous support of donors to carry out their mission.

CVP Management, Inc (Converge Venture Partners) is a venture capital firm founded in 1998 by Nilanjana Bhowmik and Maia Heymann. The firm is headquartered in Cambridge, Massachusetts.

Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell.